Takeda Pharmaceutical Co (FRA:TKDA) Other Operating Expense : €5,050 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Other Operating Expense?

Takeda Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was €1,454 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €5,050 Mil.

Takeda Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (€405 Mil) to Dec. 2024 (€1,918 Mil) but then declined from Dec. 2024 (€1,918 Mil) to Mar. 2025 (€1,454 Mil).

Takeda Pharmaceutical Co's annual Other Operating Expense increased from Mar. 2023 (€4,178 Mil) to Mar. 2024 (€4,497 Mil) and increased from Mar. 2024 (€4,497 Mil) to Mar. 2025 (€5,112 Mil).

Takeda Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Takeda Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Other Operating Expense Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Operating Expense

Get a 7-Day Free Trial

3,511.92

3,856.82

4,177.81

4,497.42

5,111.93

Takeda Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															555.54	1,272.42	404.91	1,918.00	1,454.48

Takeda Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,050 Mil.

Takeda Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (FRA:TKDA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 0A87:UK TKD:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines